Here we investigate this hypothesis by using cell-based assays to measure human MOR-mediated G protein signaling and βarrestin2 recruitment by desmetramadol, each of its enantiomers, and clinically relevant control opioids having moderate (morphine, oxycodone) and high (fentanyl) propensity for clinical respiratory depression. This evidence concerns the gene OPRM1 and respiratory depression.